超两倍溢价收购背后，天有为瞄上欧洲高端车市：100万欧元买下资不抵债的德国克莱默 标的资不抵债 12月9日晚间，天有为公告称，拟使用100万欧元自有资金购买MS-ONE Holding AG持有的Krämer Automotive Systems GmbH(以下简称"克莱默")100%的股权。天有为表示，本次收购事项符合公司国际 化发展的战略，有利于公司更好开拓欧洲市场客户，特别是高端乘用车客户，有助于提升公司盈利能力 与可持续发展能力，增强公司的市场竞争力与行业地位。 克莱默总部位于德国，是成立于1974年的老牌汽车电子系统制造商。公司早期主要专注于汽车电子和信 息娱乐系统的研发与生产，为欧洲多家车企提供定制化的车载电子解决方案。克莱默曾经与保时捷 (Porsche)、路虎(Land Rover)、捷豹(Jaguar)等高端汽车品牌建立了联系。奔驰也是克莱默的客户之一。 不过根据德国媒体今年8月报道，由于未收到重大订单，克莱默财务出现困难，向当地法院提出了破产 申请。根据媒体报道内容，该公司18名员工的薪资由三个月的破产补助覆盖。 记者｜胥帅 12月9日晚间，4月刚登陆A股的天有为(SH603202，股价9 ...

Core Viewpoint - The company plans to acquire 100% of Krmer Automotive Systems GmbH for €1 million, which will enhance its market position and operational capabilities in the automotive sector [1][2][3] Group 1: Acquisition Details - The acquisition will be funded using the company's own funds and will result in Krmer being fully consolidated into the company's financial statements [1] - Krmer specializes in the development and manufacturing of in-vehicle infotainment systems, digital cockpits, and connected vehicle solutions [1] - The acquisition aligns with the company's strategy to expand its international presence and enhance its product offerings [3] Group 2: Strategic Implications - The acquisition is expected to positively impact the company's future development by leveraging Krmer's sales team and customer relationships, particularly with high-end automotive manufacturers [2] - It will strengthen the company's sales channel in Europe and improve its competitive position in the region [2][3] - The integration of Krmer's operations is anticipated to create synergies in technology development and market resource sharing, benefiting both entities [2][3] Group 3: Future Growth Plans - The company aims to continue developing its automotive instrument business while expanding its global market share and seeking growth opportunities in international markets [2] - Plans include establishing subsidiaries and production bases in Mexico and South Korea to enhance responsiveness to international clients [2] - The company expects its new factory in Mexico to begin operations by June 2025, targeting the North American market [2]

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

证券代码：603202 证券简称：天有为 公告编号：2025-045 黑龙江天有为电子股份有限公司 关于购买 Krämer Automotive Systems GmbH 100%股权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 黑龙江天有为电子股份有限公司（以下简称"公司"）拟使用 1,000,000.00 欧元自有资金购买 MS-ONE Holding AG 持有的 Krämer Automotive Systems GmbH（以下简称"标的公司"、"克莱默"）100%的股权（以下简称"本次收 购"）。本次收购完成后，公司将持有标的公司 100%股权，标的公司将纳入公 司合并报表范围。 本次交易不构成关联交易，亦不构成《上市公司重大资产重组管理办 法》规定的重大资产重组，预计不存在重大法律障碍。 根据《上海证券交易所股票上市规则》《黑龙江天有为电子股份有限 公司章程》（以下简称"《公司章程》"）及相关制度的规定，本次收购在 公司总经理审批权限内，并已履行内部决策程序，无需提交董事会、股东会 审议。 ...

本次收购事项符合公司国际化发展的战略，有利于公司更好开拓欧洲市场客户，特别是高端乘用车客 户，有助于提升公司盈利能力与可持续发展能力，增强公司的市场竞争力与行业地位，符合公司及全体 股东的利益。本次收购将有助于公司进一步拓展收入来源，提升资本市场及投资者对公司的价值认可 度，促进公司高质量发展。 格隆汇12月9日丨天有为(603202.SH)公布，公司拟使用100万欧元自有资金购买 MS-ONE Holding AG 持 有的 Krämer Automotive SystemsGmbH（以下简称"标的公司"、"克莱默"）100%的股权（以下简称"本 次收购"）。本次收购完成后，公司将持有标的公司 100%股权，标的公司将纳入公司合并报表范围。 ...

本次收购事项符合公司国际化发展的战略，有利于公司更好开拓欧洲市场客户，特别是高端乘用车客 户，有助于提升公司盈利能力与可持续发展能力，增强公司的市场竞争力与行业地位，符合公司及全体 股东的利益。本次收购将有助于公司进一步拓展收入来源，提升资本市场及投资者对公司的价值认可 度，促进公司高质量发展。 智通财经APP讯，天有为(603202.SH)发布公告，公司拟使用100万欧元自有资金购买MS-ONE Holding AG 持有的 Krämer Automotive Systems GmbH(以下简称"标的公司"、"克莱默")100%的股权。本次收购 完成后，公司将持有标的公司100%股权，标的公司将纳入公司合并报表范围。 ...

智通财经APP讯，天有为(603202.SH)发布公告，公司拟使用100万欧元自有资金购买MS-ONE Holding AG 持有的 Krämer Automotive Systems GmbH(以下简称"标的公司"、"克莱默")100%的股权。本次收购 完成后，公司将持有标的公司100%股权，标的公司将纳入公司合并报表范围。 本次收购事项符合公司国际化发展的战略，有利于公司更好开拓欧洲市场客户，特别是高端乘用车客 户，有助于提升公司盈利能力与可持续发展能力，增强公司的市场竞争力与行业地位，符合公司及全体 股东的利益。本次收购将有助于公司进一步拓展收入来源，提升资本市场及投资者对公司的价值认可 度，促进公司高质量发展。 ...

人民财讯12月9日电，天有为（603202）12月9日公告，公司拟使用100万欧元自有资金购买MS-ONE Holding AG持有的Kr mer Automotive Systems GmbH(克莱默汽车系统有限公司，简称"克莱默")100%的 股权。本次收购完成后，公司将持有克莱默100%股权。本次收购事项符合公司国际化发展的战略，有 利于公司更好开拓欧洲市场客户，特别是高端乘用车客户，有助于提升公司盈利能力与可持续发展能 力，增强公司的市场竞争力与行业地位。 ...

Summary of Key Points Core Viewpoint - The news highlights the issuance of new stocks in the market, detailing the total amount raised by various companies and the distribution of these funds across different sectors and regions. Group 1: New Stock Issuance - Yuan Chuang Co., Ltd. issued 19.6 million shares at a price of 24.75 yuan, raising 485 million yuan [1] - A total of 102 companies have gone public this year, raising a cumulative amount of 120.164 billion yuan, with an average fundraising of 1.178 billion yuan per company [1] - Among these, 28 companies raised over 1 billion yuan, and 1 company raised over 10 billion yuan [1] Group 2: Fundraising by Sector - The Shanghai Stock Exchange saw 21 new stocks issued, raising 41.405 billion yuan; the Shenzhen Stock Exchange had 13 new stocks raising 15.082 billion yuan; the ChiNext Board issued 29 new stocks raising 22.662 billion yuan; the Sci-Tech Innovation Board had 16 new stocks raising 34.310 billion yuan; and the Beijing Stock Exchange issued 23 new stocks raising 6.705 billion yuan [1] - Huadian New Energy is the top fundraiser this year, raising 18.171 billion yuan primarily for wind and solar power projects [2] - C Moer raised 8 billion yuan for the development of AI chips and graphics chips [2] Group 3: Pricing and Regional Distribution - The average initial public offering (IPO) price this year is 23.44 yuan, with 8 companies priced above 50 yuan and 2 above 100 yuan [2] - Jiangsu, Guangdong, and Zhejiang are the top regions for new stock issuances, with 24, 18, and 16 companies respectively [2] - The highest IPO price was for C Moer at 114.28 yuan, while the lowest was for Huadian New Energy at 3.18 yuan [2]

具体从归属地来看，江苏省有24家企业登陆A股，其中德力佳、丰倍生物、华新精科、天富龙、技 源集团、海阳科技、华之杰在沪市主板上市，江顺科技在深市主板上市，联合动力、汉桑科技、泽润新 能、众捷汽车、泰禾股份、惠通科技、常友科技在创业板上市，汉邦科技、胜科纳米、赛分科技在科创 板上市，中诚咨询、长江能科、三协电机、酉立智能、鼎佳精密、天工股份在北交所上市。上述24家企 业合计募集资金总额158.74亿元。 广东省有19家企业登陆A股，其中马可波罗、瑞立科密、悍高集团、新亚电缆在深市主板上市，南 网数字、广东建科、同宇新材、优优绿能、钧崴电子、弘景光电、矽电股份、宏工科技、首航新能、太 力科技、超研股份在创业板上市，必贝特、影石创新在科创板上市，南特科技、奥美森在北交所上市。 上述19家企业合计募集资金总额176.70亿元。 浙江省有14家企业登陆A股，其中大明电子、中策橡胶、肯特催化、泰鸿万立、永杰新材在沪市主 板上市，信凯科技、富岭股份在深市主板上市，思看科技在科创板上市，汉朔科技、浙江华业、浙江华 远在创业板上市，锦华新材、能之光、志高机械在北交所上市。上述14家企业合计募集资金总额114.30 亿元。 上海 ...